This inventor holds 1 USPTO granted patent. Top assignee: Alteogen, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovator Spotlight: Jaehyeong Ko and His Groundbreaking Patent
Introduction: Jaehyeong Ko, an innovative scientist based in Daejeon, South Korea, has made significant strides in the field of biotechnology. His noteworthy contributions have culminated in a patent that could have a considerable impact on the treatment of growth hormone-related disorders.
Latest Patents: Ko holds a patent for "Growth hormone receptor antagonists and fusion proteins thereof." This pioneering invention relates to a growth hormone receptor antagonist that comprises a growth hormone variant modified by the substitution of one or more amino acids. Notably, this antagonist can also incorporate a long-acting carrier fused to the growth hormone variant. The invention boasts a strong binding potency to the growth hormone receptor, providing long-lasting antagonistic action, which could revolutionize therapeutic approaches to growth hormone pathologies.
Career Highlights: Jaehyeong Ko is currently associated with Alteogen, Inc., a company that focuses on novel therapeutics in the biopharmaceutical sector. His expertise in biochemistry and molecular biology has been instrumental in the development of groundbreaking therapeutic options. His commitment to research and innovation has made him a key player in the ever-evolving landscape of biotechnology.
Collaborations: Throughout his career, Ko has worked alongside several esteemed colleagues, including Soon Jae Park and Sun-Ah You. These collaborations have fostered a dynamic research environment that encourages the sharing of knowledge and expertise, further enhancing the quality and applicability of their innovative works.
Conclusion: Jaehyeong Ko stands out as a prominent inventor whose work in growth hormone receptor antagonism represents a significant advancement in medical science. His dedication to pushing the boundaries of innovation has the potential to lead to improved treatment options for individuals suffering from growth hormone disorders. As he continues to develop new ideas and collaborate with fellow researchers, the future looks bright for this talented inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
